Pro-Pharmaceuticals announced that the company and Jetai Technology Co., Ltd. recently signed a “Strategic Cooperation Framework Agreement”. The two sides have formed a strategic partnership to carry out long-term cooperation on CDMO and other related projects. The cooperation includes CDMO service cooperation, potential capital and industry collaboration, and joint development of improved new drugs. This agreement is a framework agreement. It does not involve a substantive transaction, does not constitute a related transaction, and does not constitute a major asset restructuring. The agreement is valid for five years, and there is no significant impact on the company's operating performance this year.

Pro-Pharmaceuticals announced that the company and Jetai Technology Co., Ltd. recently signed a “Strategic Cooperation Framework Agreement”. The two sides have formed a strategic partnership to carry out long-term cooperation on CDMO and other related projects. The cooperation includes CDMO service cooperation, potential capital and industry collaboration, and joint development of improved new drugs. This agreement is a framework agreement. It does not involve a substantive transaction, does not constitute a related transaction, and does not constitute a major asset restructuring. The agreement is valid for five years, and there is no significant impact on the company's operating performance this year.